| Name | Publix Pharmacy #0026 |
|---|---|
| Organization Name | Publix Super Markets, Inc |
| Location | 1735 Buford Hwy, Cumming, Georgia 30041 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (770) 781-8152 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
While laser and light-based therapies continue to make their mark on many dermatologic procedures, some dermatologists believe the tried-and-true oral medications for treating moderate to severe acne offer patients the best long-term treatment outcomes.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
A new study has found that a multi-component self-management intervention for adults with epilepsy may be an important tool to increase efficiency in epilepsy care.
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).
› Verified 6 days ago
| NPI Number | 1437198447 |
| Organization Name | PUBLIX SUPER MARKETS INC |
| Doing Business As | PUBLIX PHARMACY #0026 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1735 Buford Hwy, Cumming, GA 30041 |
| Phone Number | 770-781-8152 |
News Archive
While laser and light-based therapies continue to make their mark on many dermatologic procedures, some dermatologists believe the tried-and-true oral medications for treating moderate to severe acne offer patients the best long-term treatment outcomes.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
A new study has found that a multi-component self-management intervention for adults with epilepsy may be an important tool to increase efficiency in epilepsy care.
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).
› Verified 6 days ago
News Archive
While laser and light-based therapies continue to make their mark on many dermatologic procedures, some dermatologists believe the tried-and-true oral medications for treating moderate to severe acne offer patients the best long-term treatment outcomes.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
A new study has found that a multi-component self-management intervention for adults with epilepsy may be an important tool to increase efficiency in epilepsy care.
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).
› Verified 6 days ago
First Source Catheter, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1690 Redi Rd, Cumming, Georgia 30040 Phone: (470) 839-2904 | |
Cvs Pharmacy # 04682 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4895 Post Rd, Cumming, Georgia 30040 Phone: (678) 341-6858 | |
Cvs Pharmacy #00191 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5510 Castleberry Rd, Cumming, Georgia 30040 Phone: (770) 887-7720 | |
Cvs Pharmacy #02310 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1230 Buford Rd, Cumming, Georgia 30041 Phone: (770) 887-6860 | |
Cvs Pharmacy #03882 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 450 Peachtree Pkwy, Cumming, Georgia 30041 Phone: (770) 889-1301 |